SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Advaxis, Inc. – ‘10-Q’ for 4/30/22 – ‘EX-31.1’

On:  Tuesday, 6/7/22, at 8:41pm ET   ·   As of:  6/8/22   ·   For:  4/30/22   ·   Accession #:  1493152-22-16125   ·   File #:  1-36138

Previous ‘10-Q’:  ‘10-Q’ on 3/17/22 for 1/31/22   ·   Next:  ‘10-Q’ on 9/13/22 for 7/31/22   ·   Latest:  ‘10-Q’ on 11/20/23 for 9/30/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 6/08/22  Advaxis, Inc.                     10-Q        4/30/22   73:4.7M                                   M2 Compliance LLC/FA

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    761K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     27K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     27K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     22K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     22K 
11: R1          Cover                                               HTML     74K 
12: R2          Condensed Consolidated Balance Sheets               HTML    109K 
13: R3          Condensed Consolidated Balance Sheets               HTML     51K 
                (Parenthetical)                                                  
14: R4          Condensed Consolidated Statements of Operations     HTML     85K 
                (Unaudited)                                                      
15: R5          Condensed Consolidated Statements of Cash Flows     HTML    108K 
                (Unaudited)                                                      
16: R6          Nature of Operations                                HTML     32K 
17: R7          Summary of Significant Accounting Policies and      HTML     47K 
                Basis of Presentation                                            
18: R8          Property and Equipment                              HTML     32K 
19: R9          Intangible Assets                                   HTML     41K 
20: R10         Accrued Expenses                                    HTML     28K 
21: R11         Leases                                              HTML     54K 
22: R12         Common Stock Purchase Warrants and Warrant          HTML     80K 
                Liability                                                        
23: R13         Commitments and Contingencies                       HTML     30K 
24: R14         Temporary Equity                                    HTML     43K 
25: R15         Stockholders? Equity                                HTML     75K 
26: R16         Share Based Compensation                            HTML     74K 
27: R17         Licensing Agreements                                HTML     30K 
28: R18         Fair Value                                          HTML     60K 
29: R19         Summary of Significant Accounting Policies and      HTML     61K 
                Basis of Presentation (Policies)                                 
30: R20         Summary of Significant Accounting Policies and      HTML     28K 
                Basis of Presentation (Tables)                                   
31: R21         Property and Equipment (Tables)                     HTML     28K 
32: R22         Intangible Assets (Tables)                          HTML     36K 
33: R23         Accrued Expenses (Tables)                           HTML     28K 
34: R24         Leases (Tables)                                     HTML     55K 
35: R25         Common Stock Purchase Warrants and Warrant          HTML     67K 
                Liability (Tables)                                               
36: R26         Temporary Equity (Tables)                           HTML     28K 
37: R27         Stockholders? Equity (Tables)                       HTML     70K 
38: R28         Share Based Compensation (Tables)                   HTML     74K 
39: R29         Fair Value (Tables)                                 HTML     59K 
40: R30         Nature of Operations (Details Narrative)            HTML     24K 
41: R31         Schedule of Anti -Diluted Securities Excluded From  HTML     28K 
                Diluted Net Loss Per Share (Details)                             
42: R32         Summary of Significant Accounting Policies and      HTML     28K 
                Basis of Presentation (Details Narrative)                        
43: R33         Schedule of Property and Equipment (Details)        HTML     33K 
44: R34         Property and Equipment (Details Narrative)          HTML     31K 
45: R35         Summary of Intangible Assets (Details)              HTML     34K 
46: R36         Schedule of Carrying Value of Intangible Assets     HTML     36K 
                (Details)                                                        
47: R37         Intangible Assets (Details Narrative)               HTML     29K 
48: R38         Summary of Accrued Expenses (Details)               HTML     32K 
49: R39         Schedule of Supplemental Balance Sheet Related to   HTML     29K 
                Leases (Details)                                                 
50: R40         Schedule of Lease Expenses (Details)                HTML     30K 
51: R41         Schedule of Other Information Related to Leases     HTML     25K 
                (Details)                                                        
52: R42         Schedule of Cash Flow Information Related to        HTML     23K 
                Leases (Details)                                                 
53: R43         Schedule of Future Minimum Lease Payments Under     HTML     32K 
                Non-Cancellable Leases (Details)                                 
54: R44         Leases (Details Narrative)                          HTML     39K 
55: R45         Schedule of Common Stock Purchase Warrants and      HTML     45K 
                Warrant Liability (Details)                                      
56: R46         Schedule of Assumptions Used in Warrant Liability   HTML     39K 
                (Details)                                                        
57: R47         Common Stock Purchase Warrants and Warrant          HTML     55K 
                Liability (Details Narrative)                                    
58: R48         Schedule of Preferred Stock Redemption Liability    HTML     31K 
                (Details)                                                        
59: R49         Temporary Equity (Details Narrative)                HTML     62K 
60: R50         Summary of Stockholders Equity (Details)            HTML     99K 
61: R51         Summary of Share Based Compensation Expense         HTML     28K 
                (Details)                                                        
62: R52         Summary of Changes in Stock Option Plan (Details)   HTML     48K 
63: R53         Summary of Outstanding and Exercisable Options      HTML     57K 
                (Details)                                                        
64: R54         Share Based Compensation (Details Narrative)        HTML     30K 
65: R55         Licensing Agreements (Details Narrative)            HTML     39K 
66: R56         Schedule of Fair Value, Assets and Liabilities      HTML     56K 
                Measured on Recurring Basis (Details)                            
67: R57         Schedule of Fair Value, Assets and Liabilities      HTML     25K 
                Measured on Recurring Basis (Details)                            
                (Parenthetical)                                                  
68: R58         Schedule of Fair Value Measuring Unobservable       HTML     38K 
                Inputs (Details)                                                 
71: XML         IDEA XML File -- Filing Summary                      XML    129K 
69: XML         XBRL Instance -- form10-q_htm                        XML   1.15M 
70: EXCEL       IDEA Workbook of Financial Reports                  XLSX     77K 
 7: EX-101.CAL  Inline XBRL Taxonomy Extension Calculation           XML    167K 
                Linkbase Document -- adxs-20220430_cal                           
 8: EX-101.DEF  Inline XBRL Taxonomy Extension Definition Linkbase   XML    377K 
                Document -- adxs-20220430_def                                    
 9: EX-101.LAB  Inline XBRL Taxonomy Extension Label Linkbase        XML    811K 
                Document -- adxs-20220430_lab                                    
10: EX-101.PRE  Inline XBRL Taxonomy Extension Presentation          XML    636K 
                Linkbase Document -- adxs-20220430_pre                           
 6: EX-101.SCH  Inline XBRL Taxonomy Extension Schema Document --    XSD    131K 
                adxs-20220430                                                    
72: JSON        XBRL Instance as JSON Data -- MetaLinks              291±   404K 
73: ZIP         XBRL Zipped Folder -- 0001493152-22-016125-xbrl      Zip    139K 


‘EX-31.1’   —   Certification — §302 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 

EXHIBIT 31.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO 18.U.S.C. 7350

(SECTION 302 OF THE SARBANES OXLEY ACT OF 2002)

 

I, Kenneth Berlin, certify that:

 

1. I have reviewed this annual report on Form 10-Q for the quarter ended April 30, 2022 of Advaxis, Inc.;
     
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
     
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
     
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
   
  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
     
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
   
  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

June 7, 2022  
   
By: /s/ Kenneth Berlin  
Name:  Kenneth Berlin  
Title: President and Chief Executive Officer  

 

 C: 
 

Dates Referenced Herein

This ‘10-Q’ Filing    Date    Other Filings
Filed as of:6/8/22None on these Dates
Filed on:6/7/22
For Period end:4/30/22
 List all Filings 
Top
Filing Submission 0001493152-22-016125   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 5:08:49.1pm ET